Cargando…
Harnessing the Immune System: Current and Emerging Immunotherapy Strategies for Pediatric Acute Lymphoblastic Leukemia
Treatment for relapsed acute lymphoblastic leukemia (ALL) in children and young adults continues to evolve. Despite optimization of cytotoxic chemotherapeutic approaches and risk-adapted therapy, about 12% of pediatric patients still relapse, and survival rates in this population remain poor. Salvag...
Autores principales: | Glasser, Chana L., Chen, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377227/ https://www.ncbi.nlm.nih.gov/pubmed/37509525 http://dx.doi.org/10.3390/biomedicines11071886 |
Ejemplares similares
-
New and Emerging Targeted Therapies for Pediatric Acute Myeloid Leukemia (AML)
por: Chen, Jing, et al.
Publicado: (2020) -
Strategies and Advancements in Harnessing the Immune System for Gastric Cancer Immunotherapy
por: Subhash, Vinod Vijay, et al.
Publicado: (2015) -
Immunotherapy for Pediatric Acute Lymphoblastic Leukemia: Recent Advances and Future Perspectives
por: Lv, Meng, et al.
Publicado: (2022) -
Translational advances in the treatment of childhood acute lymphoblastic leukemia: narrative review of current and emerging molecular and immunotherapies
por: Munir, Faryal, et al.
Publicado: (2023) -
Pediatric acute lymphoblastic leukemia
por: Inaba, Hiroto, et al.
Publicado: (2020)